Cached score snapshot
US.LH · Labcorp
110分制 69/110;5D動能v2 29/50;排序分 98/160 · Incomplete inputs
Score breakdown
謹慎買入
Score and price trend
Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.
Move the mouse over the chart lines to inspect readings.
- Main score
- 5D momentum v2
- Candlestick
- Historical projection
- Score turn
- Setup grade
| Model | Median | P25/P75 | Win rate | Down5 | Actual / compare |
|---|---|---|---|---|---|
| Rolling DOE best | -0.23% | -2.15% / +1.78% | 46.2% | 6.8% | Actual outcome pending · 0 / 3 bars observed |
| 30D observation | +1.99% | -6.37% / +8.58% | 56.4% | 28% | Actual outcome pending · 0 / 30 bars observed |
| Historical projection 10D n=160 | -0.34% | -2.39% / +1.58% | 43.8% | 6.9% | Actual outcome pending · 0 / 10 bars observed |
Historical projection is based on archived similar setups. It is not a recommendation or guaranteed forecast.
2026-04-30 → 2026-09-07 · 90 archived points · 5 Improving turn signal · 5 Deteriorating signal
Summary
score_with_momentum_v2 = main score + 5D momentum v2
Rolling setup rating
Setup quality, historical edge, and risk are combined into a rolling S/A/B/C/D/F grade for this snapshot date.
Score turn monitor
Has the score quality changed?
Run more market refreshes to build enough archived points for a turn check.
Signals
技術信號 22.3 · 資金流 15.6 · 5D動能v2 29 · Incomplete inputs
INSTITUTIONAL_DATA_OPTIONAL: Institutional ownership unavailable; neutral money-flow treatment used. FMP_INSTITUTIONAL_FAILED: FMP HTTP 402
Audit trace
Full calculation detail
Calculation detail · 8 sections
Incomplete score
此 snapshot 已計出評分,但以下輸入仍不完整;缺失維度以 0 分處理,請留意 audit 明细。
- VIX_MISSING: VIX market context is required for market environment scoring
Market inputs
Metrics snapshot
110-point main rating
基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10
基本面 — 3.3/5 · 一般
Sub-items
資金流 — 15.6/20 · 良好
Sub-items
institutional
details
warning
市場環境 — 4.6/15 · 較差
Sub-items
vix
details
trend
details
qqq
spy
催化劑 — 10/20 · 較差
Sub-items
catalyst
details
風險管理 — 7.2/10 · 良好
Sub-items
position
details
stopLevels
strength_details
diversification
details
技術信號 — 22.3/30 · 良好
Sub-items
vcpPayload
vcp_metrics
情緒分析 — 6/10 · 一般
Sub-items
sentiment
details
sentimentData
Dimension contribution
5D momentum v2 breakdown
Cursor_18.25 5D momentum v2 0-50
Risk management
position
details
stopLevels
strength_details
diversification
details
Calculation audit log
基本面分析總分: 3.3/5分 資金流分析總分: 15.6/20分 市場環境分析總分: 4.6/15分 催化劑分析: 10/20分 風險管理總分: 7.2/10分 技術信號分析總分: 22.3/30分 情緒分析: 6/10分 共振率(僅顯示不加分): 0%
Technical indicators
adx
atr
cci
cmf
kdj
mfi
obv
rsi
sar
ma50
macd
vwap
volume
derived
ma_cross
bollinger
rsi_short
macd_short
volume_ratio
Raw calculation JSON
{
"risk": {
"level": "Medium",
"reason": "risk management score >= 6.5/10",
"position": {
"score": 1.6,
"details": {
"atrPct": 2.7037505046050616,
"turnoverUsdM": 257.24270026224,
"liquidityPoints": 0.6,
"volatilityPoints": 1
}
},
"rrPoints": 1.8,
"stopLevels": {
"symbol": "US.LH",
"rr_range": "1:1.0-1:2.5",
"risk_profile": "中等",
"stop_loss_price": 285.0072,
"strength_details": {
"ma_score": 1.5,
"atr_score": 2,
"rsi_score": 3,
"macd_score": 3,
"volume_score": 2
},
"market_adjustment": 1,
"risk_reward_ratio": 1.7,
"stop_loss_percent": 5.4,
"take_profit_price": 329.3779,
"target_multiplier": 2.2,
"technical_strength": 2.35,
"take_profit_percent": 9.3
},
"positionPoints": 1.6,
"stopLossPoints": 1.8,
"diversification": {
"score": 2,
"details": {
"method": "sector concentration proxy; no portfolio holdings used",
"sector": "Health Care",
"concentratedSectorPenalty": 0
}
},
"riskRewardRatio": 1.7198332435186094,
"stopLossPercent": 5.407501009210123,
"diversificationPoints": 2
},
"total": {
"max": 160,
"result": 98,
"formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
"baseScore": 69,
"modelVersion": "cursor_18_27_news_v2_160",
"momentum5dScore": 29
},
"market": {
"ma20": 282.5975,
"ma50": 269.4468,
"close": 301.3,
"prevClose": 296.77,
"avgVolume20": 716314,
"volumeRatio": 1.19,
"changePercent": 1.53
},
"sources": {
"catalyst": "finnhub_news_keyword_model",
"sentiment": "finnhub_news_keyword_model",
"fundamentals": "fmp_stable",
"institutional": null,
"marketContext": "twelvedata+fred"
},
"barCount": 60,
"momentum": {
"max": 50,
"result": 29,
"details": {
"ret_5d": 0.07041345493770579,
"max_score": 50,
"max_total": 50,
"raw_total": 29,
"vcp_bonus": 0,
"vol_ratio": 1.1770944059559507,
"ret_points": 12,
"vol_points": 2,
"range_ratio": 0.7999616965672256,
"volat_points": 0,
"day_range_pct": 0.020942582839116597,
"model_version": "cursor_18_27_news_v2_160",
"available_bars": 30,
"breakout_points": 8,
"partial_history": false,
"pullback_points": 3,
"breakout_vol_bonus": 0,
"first_breakout_20d": true,
"return_window_days": 5,
"first_breakout_bonus": 2,
"breakout_quality_points": 2
},
"formula": "Cursor_18.25 5D momentum v2 0-50",
"modelVersion": "cursor_18_27_news_v2_160"
},
"scoreMax": 110,
"composite": {
"max": 160,
"result": 98,
"formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
"weights": [
{
"raw": 3.3,
"label": "基本面",
"weight": "5/110",
"normalized": 66,
"contribution": 3.3
},
{
"raw": 15.6,
"label": "資金流",
"weight": "20/110",
"normalized": 78,
"contribution": 15.6
},
{
"raw": 4.6,
"label": "市場環境",
"weight": "15/110",
"normalized": 30.67,
"contribution": 4.6
},
{
"raw": 10,
"label": "催化劑",
"weight": "20/110",
"normalized": 50,
"contribution": 10
},
{
"raw": 7.2,
"label": "風險管理",
"weight": "10/110",
"normalized": 72,
"contribution": 7.2
},
{
"raw": 22.3,
"label": "技術信號",
"weight": "30/110",
"normalized": 74.33,
"contribution": 22.3
},
{
"raw": 6,
"label": "情緒分析",
"weight": "10/110",
"normalized": 60,
"contribution": 6
}
],
"modelVersion": "cursor_18_27_news_v2_160"
},
"momentumMax": 50,
"scoreStatus": "incomplete",
"standard110": {
"rating": "謹慎買入",
"result": 69,
"details": [
"基本面分析總分: 3.3/5分",
"資金流分析總分: 15.6/20分",
"市場環境分析總分: 4.6/15分",
"催化劑分析: 10/20分",
"風險管理總分: 7.2/10分",
"技術信號分析總分: 22.3/30分",
"情緒分析: 6/10分",
"共振率(僅顯示不加分): 0%"
],
"formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
"dimensionScores": {
"催化劑": 10,
"基本面": 3.3,
"資金流": 15.6,
"市場環境": 4.6,
"情緒分析": 6,
"技術信號": 22.3,
"風險管理": 7.2
},
"dimensionDetails": {
"催化劑": {
"max": 20,
"grade": "較差",
"items": {
"catalyst": {
"score": 10,
"details": {
"source": "finnhub_news_keyword_model",
"articleCount": 8,
"catalystCount": 2
}
},
"catalystPoints": 10
}
},
"基本面": {
"max": 5,
"grade": "一般",
"items": {
"pbPoints": 0.4,
"pePoints": 0.2,
"epsPoints": 0.6,
"roePoints": 0.4,
"debtPoints": 0.4,
"marginPoints": 0,
"turnoverUsdM": 257.24270026224,
"volumePoints": 0.5,
"revenuePoints": 0,
"dividendPoints": 0.3,
"marketCapPoints": 0.5
},
"source": "fmp_stable"
},
"資金流": {
"max": 20,
"grade": "良好",
"items": {
"cmfPoints": 2.4,
"mfiPoints": 3.2,
"obvPoints": 4,
"vwapPoints": 4,
"institutional": {
"score": 2,
"details": {
"source": "optional-neutral",
"warning": {
"code": "INSTITUTIONAL_DATA_OPTIONAL",
"symbol": "US.LH",
"message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
},
"optional": true,
"holderCount": null,
"holderPoints": 2,
"top10ShareRatio": null,
"concentrationPenalty": 0
}
},
"institutionPoints": 2
}
},
"市場環境": {
"max": 15,
"grade": "較差",
"items": {
"vix": {
"score": 0,
"details": {
"source": "twelvedata+fred",
"missing": true,
"vixClose": null
}
},
"trend": {
"score": 0.8,
"details": {
"qqq": {
"ma20": 710.4899991500001,
"ma50": 717.6342017599999,
"name": "QQQ",
"close": 682.059998,
"points": 0.4
},
"spy": {
"ma20": 746.6545068500001,
"ma50": 745.00220184,
"name": "SPY",
"close": 739.02002,
"points": 0.4
},
"source": "twelvedata+fred"
}
},
"atrPct": 2.7037505046050616,
"atrPoints": 3,
"cciPoints": 0.8,
"vixPoints": 0,
"marketTrendPoints": 0.8
}
},
"情緒分析": {
"max": 10,
"grade": "一般",
"items": {
"sentiment": {
"score": 6,
"details": {
"source": "finnhub_news_keyword_model",
"articleCount": 8,
"negativeHits": 0,
"positiveHits": 4,
"sentimentScoreRaw": 1.2
}
},
"sentimentData": {
"raw": [
{
"id": 141013687,
"url": "https://finnhub.io/api/news?id=799f54c6f74684aea37d6616d713755d15f5c7a914c842ec363dc06cc5365f86",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Labcorp Holdings (LH) is in focus after recent commentary highlighted rising analyst optimism ahead of its June 2026 quarter earnings, with expectations for higher revenue and year over year earnings growth. See our latest analysis for Labcorp Holdings. The Labcorp Holdings share price has gained 11.9% over the past month and 17.9% year to date. The 3 year total shareholder return of 43.4% points to sustained interest alongside the more recent pickup in momentum. If you are looking beyond...",
"category": "company",
"datetime": 1784949554,
"headline": "Labcorp Holdings (LH) Draws Fresh Earnings Optimism, Is It Still 4% Undervalued?"
},
{
"id": 141006633,
"url": "https://finnhub.io/api/news?id=8bc15cdae958b1e03a3bf47ad96f8a800793fbb0c9f62ff1e3c2727201fc0b67",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Labcorp (LH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
"category": "company",
"datetime": 1784898903,
"headline": "Labcorp Holdings Inc. (LH) Hit a 52 Week High, Can the Run Continue?"
},
{
"id": 141005500,
"url": "https://finnhub.io/api/news?id=cf321bf4499cb34d67bd3155505fe14aad25737f6e0ad655428bfb506f3d8909",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Labcorp Holdings recently drew attention as analysts revised their earnings estimates slightly higher ahead of its June 2026 quarter results, reflecting expectations for higher revenue and year-over-year earnings growth. This shift in analyst forecasts suggests growing confidence in Labcorp’s near-term profit outlook, adding a new layer to its existing growth story. We’ll now examine how this recent uptick in earnings expectations could influence Labcorp’s broader investment narrative and...",
"category": "company",
"datetime": 1784895208,
"headline": "Should Analyst Upgrades to Earnings Outlook Require Action From Labcorp (LH) Investors?"
},
{
"id": 141005501,
"url": "https://finnhub.io/api/news?id=e1eb576a72c7615322455ae0cd570713531a7773fa0827731f418500bdb15d0d",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Labcorp (LH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.",
"category": "company",
"datetime": 1784892240,
"headline": "Strength Seen in Labcorp (LH): Can Its 3.4% Jump Turn into More Strength?"
},
{
"id": 140995016,
"url": "https://finnhub.io/api/news?id=f756aef7c16ca88263e9cec4c199547710d5673f667c497c10b233e0f3a16a84",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Labcorp (LH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
"category": "company",
"datetime": 1784815238,
"headline": "Labcorp Holdings (LH) Earnings Expected to Grow: Should You Buy?"
},
{
"id": 140973589,
"url": "https://finnhub.io/api/news?id=d26bc0967a3ca10425daa181efc6cbf68be3ce0a2bce89bb5a9af85d196ccf08",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Labcorp (LH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
"category": "company",
"datetime": 1784650204,
"headline": "Will Labcorp (LH) Beat Estimates Again in Its Next Earnings Report?"
},
{
"id": 140782807,
"url": "https://finnhub.io/api/news?id=67d747b0e4de7ac62347615064d2cb439961b24f91a7a1a938f941d01938ecdb",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "LH vs. CRL: Which Stock Is the Better Value Option?",
"category": "company",
"datetime": 1782920405,
"headline": "LH or CRL: Which Is the Better Value Stock Right Now?"
},
{
"id": 140745849,
"url": "https://finnhub.io/api/news?id=9f134601870442471946463b5cc9525da1a4984250f9aa0de6304425ca886362",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Earlier this week, Labcorp announced the nationwide availability of ColoSense, the first FDA-approved RNA-based at-home colorectal cancer screening test, now covered for eligible Medicare and Medicare Advantage patients and aligned with major U.S. screening guidelines. The test’s combination of RNA biomarker detection for both cancer and advanced adenomas, plus a simplified at-home collection process, positions it as a potentially important addition to Labcorp’s colorectal screening...",
"category": "company",
"datetime": 1782562268,
"headline": "Why Labcorp (LH) Is Up 6.1% After FDA Approval, Medicare Coverage Of ColoSense At-Home Test"
}
],
"raw_source": [
{
"id": 141037184,
"url": "https://finnhub.io/api/news?id=22c4f92f3c88f3a96febcbbeb9e4c85d408b1e74e67000b972ad008f6e93b1f6",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Bank of America's trading, investment banking and digital expansion drive growth, but rising costs and market volatility pose key challenges.",
"category": "company",
"datetime": 1785183300,
"headline": "Top Stock Reports for Bank of America, Netflix & TotalEnergies"
},
{
"id": 141032302,
"url": "https://finnhub.io/api/news?id=d0f43c1bd24348255c879346e693ffebd977e061af8d4fb785a2c68cddcb3e01",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the launch of Marker by Labcorp™ Genetic Health Panel, a new offering designed to help consumers better understand inherited risks associated with more than 100 medically actionable health conditions. Available through Labcorp OnDemand, the panel analyzes 163 genes associated with hereditary cancer, cardiovascular conditions and metabolic conditions and includes access to licensed genetic cou",
"category": "company",
"datetime": 1785153600,
"headline": "Labcorp Launches Marker by Labcorp™ Genetic Health Panel, Expanding Consumer Access to Hereditary Genetic Risk Testing"
},
{
"id": 141013687,
"url": "https://finnhub.io/api/news?id=799f54c6f74684aea37d6616d713755d15f5c7a914c842ec363dc06cc5365f86",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Labcorp Holdings (LH) is in focus after recent commentary highlighted rising analyst optimism ahead of its June 2026 quarter earnings, with expectations for higher revenue and year over year earnings growth. See our latest analysis for Labcorp Holdings. The Labcorp Holdings share price has gained 11.9% over the past month and 17.9% year to date. The 3 year total shareholder return of 43.4% points to sustained interest alongside the more recent pickup in momentum. If you are looking beyond...",
"category": "company",
"datetime": 1784949554,
"headline": "Labcorp Holdings (LH) Draws Fresh Earnings Optimism, Is It Still 4% Undervalued?"
},
{
"id": 141006632,
"url": "https://finnhub.io/api/news?id=905eab1e184b5839c349ef11a85fea84bad91ef2e2ad7e118471fa28526f3158",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "BrightSpring Health Services, Inc. (BTSG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
"category": "company",
"datetime": 1784901613,
"headline": "BrightSpring Health Services, Inc. (BTSG) Earnings Expected to Grow: Should You Buy?"
},
{
"id": 141006633,
"url": "https://finnhub.io/api/news?id=8bc15cdae958b1e03a3bf47ad96f8a800793fbb0c9f62ff1e3c2727201fc0b67",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Labcorp (LH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
"category": "company",
"datetime": 1784898903,
"headline": "Labcorp Holdings Inc. (LH) Hit a 52 Week High, Can the Run Continue?"
},
{
"id": 141005499,
"url": "https://finnhub.io/api/news?id=adadddc876ba84463f58b1cf0662436d7a28ed432082d12c778cbd0425044113",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 9.7% over the past six months, topping the S&P 500 by 1.8 percentage points.",
"category": "company",
"datetime": 1784898308,
"headline": "1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds"
},
{
"id": 141005500,
"url": "https://finnhub.io/api/news?id=cf321bf4499cb34d67bd3155505fe14aad25737f6e0ad655428bfb506f3d8909",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Labcorp Holdings recently drew attention as analysts revised their earnings estimates slightly higher ahead of its June 2026 quarter results, reflecting expectations for higher revenue and year-over-year earnings growth. This shift in analyst forecasts suggests growing confidence in Labcorp’s near-term profit outlook, adding a new layer to its existing growth story. We’ll now examine how this recent uptick in earnings expectations could influence Labcorp’s broader investment narrative and...",
"category": "company",
"datetime": 1784895208,
"headline": "Should Analyst Upgrades to Earnings Outlook Require Action From Labcorp (LH) Investors?"
},
{
"id": 141005501,
"url": "https://finnhub.io/api/news?id=e1eb576a72c7615322455ae0cd570713531a7773fa0827731f418500bdb15d0d",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Labcorp (LH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.",
"category": "company",
"datetime": 1784892240,
"headline": "Strength Seen in Labcorp (LH): Can Its 3.4% Jump Turn into More Strength?"
},
{
"id": 140995016,
"url": "https://finnhub.io/api/news?id=f756aef7c16ca88263e9cec4c199547710d5673f667c497c10b233e0f3a16a84",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Labcorp (LH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
"category": "company",
"datetime": 1784815238,
"headline": "Labcorp Holdings (LH) Earnings Expected to Grow: Should You Buy?"
},
{
"id": 140981940,
"url": "https://finnhub.io/api/news?id=4ef76ce27eda81d626046a0e4578b307154512d58d22f0a60cb0d85499f4330a",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "LH heads into Q2 earnings results with expectations for higher revenues and EPS, as diagnostics, specialty testing and new collaborations drive momentum.",
"category": "company",
"datetime": 1784723820,
"headline": "Labcorp Prepares to Report Q2 Earnings: What's in the Cards?"
},
{
"id": 140973589,
"url": "https://finnhub.io/api/news?id=d26bc0967a3ca10425daa181efc6cbf68be3ce0a2bce89bb5a9af85d196ccf08",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Labcorp (LH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
"category": "company",
"datetime": 1784650204,
"headline": "Will Labcorp (LH) Beat Estimates Again in Its Next Earnings Report?"
},
{
"id": 140960859,
"url": "https://finnhub.io/api/news?id=97af80ad8ab4420f78a1207f54a4d08df4680ba053061f1404d83440a6f0dda2",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "EW heads into Q2 earnings results with estimates calling for double-digit revenue growth as TAVR, TMTT and Surgical heart businesses remain in focus.",
"category": "company",
"datetime": 1784553780,
"headline": "Edwards' Q2 Earnings on the Horizon: What's in the Cards?"
},
{
"id": 140917339,
"url": "https://finnhub.io/api/news?id=1f27600ea334c5b64cdbb9db553eb2b5fbc9ef3641296bb4fc92f47cd3e9094a",
"image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1442853868/image_1442853868.jpg?io=getty-c-w1536",
"source": "SeekingAlpha",
"related": "LH",
"summary": "Labcorp (LH) stock: rollup strategy, automation-driven cost cuts, and predictable 10% return potential with low risk. See here to know why itâs a buy.",
"category": "company",
"datetime": 1784170936,
"headline": "Labcorp Holdings: The Story Has Not Changed Materially"
},
{
"id": 140909795,
"url": "https://finnhub.io/api/news?id=1b47d596112422920f3e6d85275e61af22568009f53e93748458b83d713e1535",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
"category": "company",
"datetime": 1784121301,
"headline": "CVS Health Corporation (CVS) Soars to 52-Week High, Time to Cash Out?"
},
{
"id": 140886801,
"url": "https://finnhub.io/api/news?id=7d420c816dbd0ca60c63c87b0db6a2badae8d89bed18798b5b200cd4dd2335b1",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "CNBC's 20th annual state business rankings just upended conventional wisdom about which state economy leads the country, and the runner-up is pulling in more foreign investment than anyone else on the list while quietly carrying one of the biggest economic vulnerabilities in the nation.",
"category": "company",
"datetime": 1783957673,
"headline": "New Study Reveals Strongest State Economies, Only 1 State Was Better Than Texas"
},
{
"id": 140891074,
"url": "https://finnhub.io/api/news?id=76313e6bfc9d7a0f4adfbf977818ff53b1b4e667d0f731e94ae37e7e66c31a90",
"image": "",
"source": "Benzinga",
"related": "LH",
"summary": "B of A Securities analyst Michael Ryskin maintains Labcorp Holdings (NYSE:LH) with a Buy and raises the price target from $300 to $320.",
"category": "company",
"datetime": 1783950290,
"headline": "B of A Securities Maintains Buy on Labcorp Holdings, Raises Price Target to $320"
},
{
"id": 140891075,
"url": "https://finnhub.io/api/news?id=8e6e4fb168d8ccd5dce6fadbdbcfb7244398b77522704c310803250c4d4fae5b",
"image": "",
"source": "Benzinga",
"related": "LH",
"summary": "Baird analyst Eric Coldwell maintains Labcorp Holdings (NYSE:LH) with a Outperform and raises the price target from $335 to $338.",
"category": "company",
"datetime": 1783950166,
"headline": "Baird Maintains Outperform on Labcorp Holdings, Raises Price Target to $338"
},
{
"id": 140855913,
"url": "https://finnhub.io/api/news?id=49513bd95c37cd09ea1b913bb5e4351e83d6498e177eafca8261981d46a4cbc6",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on September 11, 2026, to stockholders of record as of the close of business on August 28, 2026.",
"category": "company",
"datetime": 1783631100,
"headline": "Labcorp Declares Quarterly Dividend"
},
{
"id": 140843493,
"url": "https://finnhub.io/api/news?id=6965288a4937947801c099381791136a3fc20a3c219a24c1ece262f5eee177a5",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Danaher's Biotechnology segment posts 7% core revenue growth as bioprocessing demand strengthened, even as weaker product demand created headwinds.",
"category": "company",
"datetime": 1783525800,
"headline": "Will Strength in Biotechnology Unit Continue to Drive DHR's Growth?"
},
{
"id": 140794209,
"url": "https://finnhub.io/api/news?id=39df4a09978ea5917a26ef91114b734dd4aa7c9ce6a35a88ec41512f4ed4c2b5",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Labcorp Holdings will report its second-quarter results by the end of this month, and analysts are anticipating a low-double-digit increase in earnings.",
"category": "company",
"datetime": 1782995368,
"headline": "Here's What to Expect From Labcorp Holdings’ Next Earnings Report"
},
{
"id": 140782807,
"url": "https://finnhub.io/api/news?id=67d747b0e4de7ac62347615064d2cb439961b24f91a7a1a938f941d01938ecdb",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "LH vs. CRL: Which Stock Is the Better Value Option?",
"category": "company",
"datetime": 1782920405,
"headline": "LH or CRL: Which Is the Better Value Stock Right Now?"
},
{
"id": 140775436,
"url": "https://finnhub.io/api/news?id=51f896da7aeb3194feed45ecec490f36c9a1d345eef1bfd7f0c6268844eef81e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2026 before the market opens on Thursday, July 30, 2026. The company will host a webcast beginning at 9:00 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the \"News & Events\" section of the Labcorp Investor Relations website at https://ir.labcorp.com. A link",
"category": "company",
"datetime": 1782850500,
"headline": "Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026"
},
{
"id": 140760977,
"url": "https://finnhub.io/api/news?id=ea6a9eca47665b7f281eafec437e4516e7575fe15b2544e24417c5ef8ca6c82c",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Omada Health, Inc. (OMDA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.",
"category": "company",
"datetime": 1782727020,
"headline": "Omada Health, Inc. (OMDA) Stock Jumps 10.5%: Will It Continue to Soar?"
},
{
"id": 140745849,
"url": "https://finnhub.io/api/news?id=9f134601870442471946463b5cc9525da1a4984250f9aa0de6304425ca886362",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Earlier this week, Labcorp announced the nationwide availability of ColoSense, the first FDA-approved RNA-based at-home colorectal cancer screening test, now covered for eligible Medicare and Medicare Advantage patients and aligned with major U.S. screening guidelines. The test’s combination of RNA biomarker detection for both cancer and advanced adenomas, plus a simplified at-home collection process, positions it as a potentially important addition to Labcorp’s colorectal screening...",
"category": "company",
"datetime": 1782562268,
"headline": "Why Labcorp (LH) Is Up 6.1% After FDA Approval, Medicare Coverage Of ColoSense At-Home Test"
}
],
"data_source": "finnhub_news_keyword_model",
"article_count": 8,
"negative_hits": 0,
"positive_hits": 4,
"recomputed_at_score": true,
"sentiment_score_raw": 1.2,
"source_article_count": 24,
"discarded_article_count": 16
},
"sentimentPoints": 6
}
},
"技術信號": {
"max": 30,
"raw": 22.3,
"grade": "良好",
"items": {
"bbPoints": 3,
"adxPoints": 3,
"sarPoints": 2.4000000000000004,
"vcpPoints": 1.4,
"macdPoints": 4,
"vcpPayload": {
"vcp_pass": false,
"vcp_score": 1.4,
"vcp_reason": "站上MA50;升放量(近10日3日);收盤突破20日高位;Ready=N;Confirm=Y",
"vcp_metrics": {
"up_days": 5,
"vol_ref": 689423.3333333334,
"down_days": 4,
"vcp_ready": false,
"above_ma50": true,
"avg_vol_10": 799320,
"avg_vol_20": 725325,
"avg_vol_30": 689423.3333333334,
"range_pct_10": 0.12104215469771516,
"range_pct_20": 0.12104215469771516,
"range_pct_30": 0.1511118105247863,
"up_expand_ok": true,
"lookback_used": 59,
"near_20d_high": true,
"contraction_ok": false,
"down_shrink_ok": false,
"up_expand_days": 3,
"breakout_20d_ok": true,
"vol_ratio_10_30": 1.1594037528949315,
"dist_to_20d_high": -0.009109786627027385,
"down_shrink_days": 0,
"breakout_level_20d": 298.57999,
"vcp_breakout_confirm": true,
"contraction_ratio_10_30": 0.8010105515734064
},
"vcp_name_en": "Volatility Contraction Pattern",
"vcp_name_zh": "波動收縮形態",
"vol_contraction": false
},
"kdjAdxPoints": 0.7,
"rsiKdjPoints": 3.2,
"volumeWeight": 2,
"maCrossPoints": 1.6,
"shortRsiPoints": 0.8,
"shortMacdPoints": 0.4,
"volConfirmPoints": 0.6,
"volumePointsTechnical": 1.2
}
},
"風險管理": {
"max": 10,
"grade": "良好",
"items": {
"position": {
"score": 1.6,
"details": {
"atrPct": 2.7037505046050616,
"turnoverUsdM": 257.24270026224,
"liquidityPoints": 0.6,
"volatilityPoints": 1
}
},
"rrPoints": 1.8,
"stopLevels": {
"symbol": "US.LH",
"rr_range": "1:1.0-1:2.5",
"risk_profile": "中等",
"stop_loss_price": 285.0072,
"strength_details": {
"ma_score": 1.5,
"atr_score": 2,
"rsi_score": 3,
"macd_score": 3,
"volume_score": 2
},
"market_adjustment": 1,
"risk_reward_ratio": 1.7,
"stop_loss_percent": 5.4,
"take_profit_price": 329.3779,
"target_multiplier": 2.2,
"technical_strength": 2.35,
"take_profit_percent": 9.3
},
"positionPoints": 1.6,
"stopLossPoints": 1.8,
"diversification": {
"score": 2,
"details": {
"method": "sector concentration proxy; no portfolio holdings used",
"sector": "Health Care",
"concentratedSectorPenalty": 0
}
},
"riskRewardRatio": 1.7198332435186094,
"stopLossPercent": 5.407501009210123,
"diversificationPoints": 2
}
}
}
},
"modelVersion": "cursor_18_27_news_v2_160",
"providerErrors": [
{
"code": "VIX_MISSING",
"symbol": "US.LH",
"message": "VIX market context is required for market environment scoring",
"missing": [
"VIX"
],
"provider": "scoring"
}
],
"rankingScoreMax": 160,
"dataCompleteness": {
"complete": false,
"missingFields": [
"VIX"
],
"optionalInputs": [
"institutionalData"
],
"requiredInputs": [
"fundamentals",
"marketContext.VIX",
"marketContext.SPY",
"marketContext.QQQ",
"catalystData",
"sentimentData",
"ATR",
"sector"
],
"optionalInputWarnings": []
},
"technicalIndicators": {
"adx": 85.71,
"atr": {
"atr": 8.1464,
"rule": "ATR / current price; lower volatility scores higher",
"score": 6,
"atr_pct": 2.7
},
"cci": {
"rule": "Cursor_18.24 CCI bands",
"level": "超買或超賣風險",
"score": 2,
"value": 214.92
},
"cmf": {
"rule": "Cursor_18.24 CMF bands",
"level": "輕微流入",
"score": 6,
"value": 0.1652
},
"kdj": {
"d": 72.75,
"j": 107.62,
"k": 84.37,
"rule": "Cursor_18.24 K/D cross",
"score": 4,
"signal": "金叉"
},
"mfi": {
"rule": "Cursor_18.24 MFI bands",
"level": "入貨中",
"score": 8,
"value": 65.19
},
"obv": {
"rule": "Cursor_18.24 recent_slope vs previous_slope",
"score": 10,
"trend": "強流入",
"value": -432824,
"recentSlope": 293677.6,
"previousSlope": -141650
},
"rsi": 67.76,
"sar": {
"rule": "Cursor_18.24 Parabolic SAR",
"score": 8,
"trend": "上升",
"value": 264.2667,
"position": "SAR喺價下",
"distancePct": 12.29,
"previousTrend": "上升"
},
"ma50": 269.4468,
"macd": {
"macd": 6.555792872774077,
"trend": "強烈看漲",
"signal": 4.957176597347194,
"histogram": 1.598616275426883
},
"vwap": {
"rule": "Cursor_18.24 VWAP 20D consecutive close",
"score": 10,
"value": 283.0411,
"position": "連續5日>VWAP",
"consecutiveAbove": 23
},
"volume": {
"rule": "Cursor_18.24 volume ratio",
"level": "有量",
"ratio": 1.19,
"score": 6,
"avgVolume": 716314,
"currentVolume": 853776
},
"derived": {
"ma20": 282.5975,
"ma50": 269.4468,
"prevClose": 296.77,
"avgVolume10": 845068,
"avgVolume20": 716314,
"changePercent": 1.53,
"avgVolumeForScore": 716314
},
"ma_cross": {
"ma20": 282.5975,
"ma50": 269.4468,
"rule": "Cursor_18.24 MA20/MA50 cross",
"cross": "多頭",
"score": 4,
"prevMa20": 281.106,
"prevMa50": 268.5092,
"spreadPct": 4.88,
"isVolumeBreakout": false
},
"bollinger": {
"lower": 268.7843,
"upper": 296.4107,
"position": "上半部"
},
"rsi_short": 84.69,
"macd_short": {
"macd": 0,
"trend": "中性",
"signal": 0,
"histogram": 0
},
"volume_ratio": {
"ratio": 1.19
}
}
}
Raw metrics JSON
{
"close": 301.3,
"volume": 853776,
"changePercent": 1.53
}
Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.